| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |